Schimmel Lawrence 4
4 · Nutex Health, Inc. · Filed Aug 2, 2022
Insider Transaction Report
Form 4
Schimmel Lawrence
DirectorChief Medical Officer
Transactions
- Conversion
Convertible Promissory Note
2022-04-02$100000.00/sh−30,375.35$3,037,535,000→ 0 totalExercise: $1.55From: 2019-11-19Exp: 2022-07-31→ Common Stock (19,597 underlying) - Conversion
Common Stock
2022-04-02$1.55/sh+19,597$30,375→ 253,645 total - Exercise of In-Money
Common Stock
2022-04-02$1.55/sh+9,799$15,188→ 263,444 total - Exercise of In-Money
Warrant
2022-04-02−9,799→ 0 totalExercise: $1.55From: 2019-11-19Exp: 2022-07-31→ Common Stock (9,799 underlying)
Footnotes (2)
- [F1]Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.
- [F2]Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.